David Winchester to Treatment Outcome
This is a "connection" page, showing publications David Winchester has written about Treatment Outcome.
Connection Strength
0.224
-
Timing of Adjuvant Radioactive Iodine Therapy Does Not Affect Overall Survival in Low- and Intermediate-Risk Papillary Thyroid Carcinoma. Am Surg. 2016 Sep; 82(9):807-14.
Score: 0.059
-
Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. J Am Coll Surg. 2011 Jul; 213(1):122-8; discussion 128-9.
Score: 0.041
-
Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009 Jun 20; 27(18):2946-53.
Score: 0.035
-
Multidisciplinary treatment of primary melanoma. Surg Clin North Am. 2009 Feb; 89(1):267-81, xi.
Score: 0.035
-
Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer. Surgery. 2022 01; 171(1):197-202.
Score: 0.021
-
Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival. Surgery. 2020 01; 167(1):19-27.
Score: 0.018
-
Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. Ann Surg. 1996 Mar; 223(3):342-7.
Score: 0.014